Quantcast

Latest Bioethics Stories

2013-09-03 23:04:06

Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis and Crohn’s disease. New York, NY (PRWEB) September 03, 2013 Researchers from the Icahn School of Medicine at Mount Sinai recently published two manuscripts in the New England Journal of Medicine regarding a new antibody used to treat both ulcerative colitis and Crohn’s disease. The journal...

2013-08-30 23:03:30

PharmScript offers insight on how long-term care facilities can work with pharmacy to comply with new CMS F309 Quality of Care Guidance regarding end of life care requirements. Edison, NJ (PRWEB) August 30, 2013 PharmScript reminds long-term care facilities that the Centers for Medicare and Medicaid Services (CMS) recently implemented new F309 Quality of Care Guidance to surveyors for determining nursing facility compliance with end of life care requirements. New guidelines specify that...

2013-08-08 13:57:33

A team from the University of Washington has unveiled a comprehensive portrait of the genome of the world’s first immortal cell line, known as HeLa. The cell line was derived in 1951 from an aggressive cervical cancer that killed Henrietta Lacks, a 31-year-old African-American tobacco farmer and mother of five – the subject of the 2010 New York Times best-seller, “The Immortal Life of Henrietta Lacks.” They will also be...

2013-08-08 10:14:45

The National Institutes of Health today announced in Nature that it has reached an understanding with the family of the late Henrietta Lacks to allow biomedical researchers controlled access to the whole genome data of cells derived from her tumor, commonly known as HeLa cells. These cells have already been used extensively in scientific research and have helped make possible some of the most important medical advances of the past 60 years. These include the development of modern vaccines,...


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »
Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'